OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Dysbiosis and Associated Stool Features Improve Prediction of Response to Biological Therapy in Inflammatory Bowel Disease
Clara Caenepeel, Gwen Falony, Kathleen Machiels, et al.
Gastroenterology (2023) Vol. 166, Iss. 3, pp. 483-495
Open Access | Times Cited: 31
Clara Caenepeel, Gwen Falony, Kathleen Machiels, et al.
Gastroenterology (2023) Vol. 166, Iss. 3, pp. 483-495
Open Access | Times Cited: 31
Showing 26-50 of 31 citing articles:
A postbiotic exopolysaccharide synergizes with Lactobacillus acidophilus to reduce intestinal inflammation in a mouse model of colitis
Chong Ma, Xiaobin Zheng, Qian Zhang, et al.
International Journal of Biological Macromolecules (2024) Vol. 291, pp. 138931-138931
Closed Access | Times Cited: 2
Chong Ma, Xiaobin Zheng, Qian Zhang, et al.
International Journal of Biological Macromolecules (2024) Vol. 291, pp. 138931-138931
Closed Access | Times Cited: 2
Gut microbial species and endotypes associate with remission in ulcerative colitis patients treated with anti-TNF or anti-integrin therapy
Fiona B. Tamburini, Anupriya Tripathi, Maxwell P. Gold, et al.
Journal of Crohn s and Colitis (2024)
Open Access | Times Cited: 1
Fiona B. Tamburini, Anupriya Tripathi, Maxwell P. Gold, et al.
Journal of Crohn s and Colitis (2024)
Open Access | Times Cited: 1
Fecal metaproteomics enables functional characterization of remission in patients with inflammatory bowel disease
M. Wolf, Julian Lange, Dirk Benndorf, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
M. Wolf, Julian Lange, Dirk Benndorf, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
CED: bessere Therapieprognose auf Basis von Dysbiosen und Stuhlmerkmalen
Zeitschrift für Gastroenterologie (2024) Vol. 62, Iss. 08, pp. 1182-1182
Closed Access
Zeitschrift für Gastroenterologie (2024) Vol. 62, Iss. 08, pp. 1182-1182
Closed Access
Peptide therapeutic leads for multi-target inhibition of inflammatory cytokines in Inflammatory Bowel Disease - computational design and in-vitro validation
Tomer Tsaban, Gali Kariv-Attias, Alisa Khramushin, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Tomer Tsaban, Gali Kariv-Attias, Alisa Khramushin, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Genetic factors that predict response and failure of biologic therapy in inflammatory bowel disease
Milena Peruhova, D. Stoyanova, Dimitrina Georgieva Miteva, et al.
World Journal of Experimental Medicine (2024) Vol. 15, Iss. 1
Closed Access
Milena Peruhova, D. Stoyanova, Dimitrina Georgieva Miteva, et al.
World Journal of Experimental Medicine (2024) Vol. 15, Iss. 1
Closed Access
The Gut Microbiota Affects Anti‐TNF Responsiveness by Activating the NAD+ Salvage Pathway in Ulcerative Colitis
Lei Jing, Lin Lv, Li Zhong, et al.
Advanced Science (2024)
Open Access
Lei Jing, Lin Lv, Li Zhong, et al.
Advanced Science (2024)
Open Access
Utilizing the gut microbiome as a biomarker of response to dietary interventions in inflammatory bowel disease: moving toward precision nutrition
Genelle Lunken
American Journal of Clinical Nutrition (2024) Vol. 119, Iss. 4, pp. 868-869
Closed Access
Genelle Lunken
American Journal of Clinical Nutrition (2024) Vol. 119, Iss. 4, pp. 868-869
Closed Access
